Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc (CNTA) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 243 transactions totaling $90.2M, demonstrating a bullish sentiment with $60.1M in net insider flow. The most recent transaction on Feb 2, 2026 involved a transaction of 140,000 shares valued at $0.
CNTA Insider Activity Summary
Who Is Buying CNTA Stock?
No significant insider buying has been recorded for CNTA in the recent period.
Who Is Selling CNTA Stock?
No significant insider selling has been recorded for CNTA in the recent period.
Is Centessa Pharmaceuticals plc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CNTA is bullish with an Insider Alignment Score of 83/100 and a net flow of $60.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CNTA Frequently Asked Questions
Understanding CNTA Insider Activity
Insider trading at Centessa Pharmaceuticals plc (CNTA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading CNTA stock, having executed 243 transactions in the past 90 days. The most active insider is Atlantic Genpar (bermuda), L.p. General (Executive), who has made 1 transactions totaling $30.0M.
Related Tools
Track Centessa Pharmaceuticals plc Insider Activity
Get notified when executives and directors at CNTA file new Form 4 transactions